|
Volumn 33, Issue 1, 2005, Pages 65-73
|
Approach to clinical trial considering medical ethics and efficacy for HbV, liposome encapsulated hemoglobin vesicle
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD SUBSTITUTES;
CELLS;
DRUG INFUSION;
ARTIFICIAL RED CELLS;
BLOOD TRANFUSION;
HEMOGLOBIN VESICLES (HBV);
HEMOGLOBIN;
ARTIFICIAL BLOOD;
HEMOGLOBIN DERIVATIVE;
LIPOSOME;
METHEMOGLOBIN;
NEO RED CELL;
BLEEDING;
BLOOD VOLUME;
DRUG EFFICACY;
DRUG SAFETY;
ENCAPSULATION;
ERYTHROCYTE TRANSFUSION;
HEART OUTPUT;
HEMODILUTION;
HUMAN;
MEDICAL ETHICS;
NONHUMAN;
OXYGEN DISSOCIATION CURVE;
OXYGEN TRANSPORT;
PH;
PHYSICAL CHEMISTRY;
REVIEW;
TISSUE OXYGENATION;
TRANSPORT VESICLE;
VISCOSITY;
BIOETHICS;
BLOOD SUBSTITUTES;
BLOOD TRANSFUSION;
CLINICAL TRIALS;
HEMOGLOBINS;
HUMANS;
LIPOSOMES;
TREATMENT OUTCOME;
|
EID: 14644399831
PISSN: 10731199
EISSN: None
Source Type: Journal
DOI: 10.1081/BIO-200046695 Document Type: Review |
Times cited : (4)
|
References (9)
|